Ipilimumab, Nivolumab, Tocilizumab and Radiation in Pretreated Patients With Advanced Pancreatic Cancer
Clinical trial NCT04258150 · TERMINATED
Trial details
- NCT number
- NCT04258150
- Sponsor
- Herlev Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-16
- Primary completion
- 2021-11-23
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.